Metastable pharmaceutical compositions

Details for Australian Patent Application No. 2003240299 (hide)

Owner Acrux DDS Pty. Ltd.

Inventors Morgan, Timothy Matthias; Wilkins, Nina Frances; Klose, Kathryn TraciJane; Reed, Barry Leonard; Finnin, Barrie Charles

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2003240299

PCT Number PCT/AU03/00785

PCT Pub. Number WO2004/000361

Priority PS 3173 25.06.02 AU

Filing date 24 June 2003

Wipo publication date 6 January 2004

Acceptance publication date 31 January 2008

International Classifications

A61K 9/12 (2006.01) Medicinal preparations characterised by special physical form - Aerosols

A61K 9/70 (2006.01) Medicinal preparations characterised by special physical form - Web, sheet or filament bases

A61K 31/137 (2006.01) - Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine

A61K 31/165 (2006.01) - having aromatic rings, e.g. colchicine, atenolol, progabide

A61K 31/216 (2006.01)

A61K 31/4025 (2006.01) - not condensed and containing further heterocyclic rings, e.g. cromakalim

A61K 31/4045 (2006.01)

A61K 31/4196 (2006.01) - 1,2,4-Triazoles

A61K 31/435 (2006.01) - having six-membered rings with one nitrogen as the only ring hetero atom

A61K 31/4468 (2006.01) - having a nitrogen atom directly attached in position 4, e.g. clebopride, fentanyl

A61K 31/473 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines

A61K 31/496 (2006.01) - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/565 (2006.01) - not substituted in position 17 beta by a carbon atom, e.g. oestrane, oestradiol

A61K 31/567 (2006.01) - substituted in position 17 alpha, e.g. mestranol, norethandrolone

A61K 31/568 (2006.01) - substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstane, testosterone

A61K 47/06 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Organic compounds

A61K 47/10 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Alcohols

A61K 47/32 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds

A61K 47/38 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Cellulose

A61M 11/00 (2006.01) Sprayers

A61P 5/24 (2006.01) Drugs for disorders of the endocrine system

A61P 13/10 (2006.01) Drugs for disorders of the urinary system

Event Publications

11 September 2003 Complete Application Filed

  Priority application(s): PS 3173 25.06.02 AU

4 March 2004 Application Open to Public Inspection

  Published as AU-B-2003240299

31 January 2008 Application Accepted

  Published as AU-B-2003240299

29 May 2008 Standard Patent Sealed

2 February 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003240300-Topical cosmetic compositions

2003240298-Render levelling strip